A Phase 1b, Multi-center Study of Intravenous (IV) Gallium Nitrate in Patients with Cystic Fibrosis (CF) Who Are Colonized with Nontuberculous Mycobacteria (NTM) (The ABATE Study)

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 12 Mar 2025

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Gallium nitrate (Primary)
Indications Cystic fibrosis-associated respiratory tract infections; Nontuberculous mycobacterium infections
Focus Adverse reactions
Acronyms ABATE; ABATE Study

13 Jan 2025 Planned primary completion date changed from 30 Sep 2024 to 30 Jun 2025.
10 Jan 2024 Planned primary completion date changed from 30 Sep 2023 to 30 Sep 2024.
10 Jan 2023 Planned End Date changed from 30 Sep 2024 to 30 Jun 2025.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com